Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Coronary Obstruction Detection by Molecular Personalized Gene Expression (COMPASS)

This study has been completed.
Cardiovascular Research Foundation, New York
Piedmont Heart Institute, Inc., Atlanta, GA
Information provided by (Responsible Party):
CardioDx Identifier:
First received: May 3, 2010
Last updated: November 25, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):